Robert Coffin
Gründer bei REPLIMUNE GROUP, INC.
Vermögen: 11 Mio $ am 30.04.2024
Aktive Positionen von Robert Coffin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REPLIMUNE GROUP, INC. | Direktor/Vorstandsmitglied | 01.03.2015 | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| Gründer | 01.03.2015 | - | |
| Vorstandsvorsitzender | 01.03.2015 | 09.01.2020 | |
| Präsident | 01.03.2015 | 01.04.2024 |
Karriereverlauf von Robert Coffin
Ehemalige bekannte Positionen von Robert Coffin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Direktor/Vorstandsmitglied | 01.01.1999 | 24.01.2013 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | 24.01.2013 | |
| Gründer | 15.10.2009 | 24.01.2013 | |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2011 | 01.01.2013 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.1999 | 04.03.2011 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | 04.03.2011 | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Direktor/Vorstandsmitglied | 01.01.1999 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | - | |
| Gründer | 01.01.1999 | - |
Ausbildung von Robert Coffin
| Imperial College London | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 3 |
Operativ
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
Sektoral
| Health Technology | 5 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
- Börse
- Insiders
- Robert Coffin
- Erfahrung
